Michelle Bradbury, MD, PhD, and Team Receive Approval for Cornell Dots Clinical Trial

August 16, 2011

SNM member Michelle Bradbury, MD, PhD, and a team of researchers have received approval from the U.S. Food and Drug Administration for the first clinical trial of a new technology that uses radiolabeled nanoparticles to brighten cancer cells so they can be detected by a PET-optical imaging camera.